British American Tobacco (BAT) has announced it will take a near 20% stake in Canadian cannabis producer Organigram for around $US175 million as it seeks to diversify its interests.
The deal will give BAT access to R&D technologies, product innovation and cannabis expertise, with an initial focus on CBD.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
